Gleeson Dermot, Evans Steven, Bradley Martin, Jones Jayne, Peck Robert J, Dube Asha, Rigby Emma, Dalton Ann
Liver Unit, Sheffield Teaching Hospitals, Sheffield, United Kingdom.
Am J Gastroenterol. 2006 Feb;101(2):304-10. doi: 10.1111/j.1572-0241.2006.00439.x.
Predisposition to alcoholic liver disease (ALD) may be partly genetic. Heterozygosity for the HFE mutations C282Y and/or H63D has been associated with more severe disease in several liver conditions. Studies in ALD have not used controls matched for alcohol consumption and results have been conflicting.
HFE genotyping was performed in two Caucasian heavy-drinking cohorts (>60 units/wk (M) or 40 units/wk (F) for >5 yr): (a) 254 patients with decompensated ALD (Child's grade B or C), (b) 130 controls with similar alcohol consumption but without liver disease. Results in males were also compared with those from another study of healthy male blood donors.
(1) Genotype distributions for the C282Y and H63D mutations were similar in ALD patients, heavy-drinking controls, and healthy blood donors. (2) ALD patients with and without HFE mutations had similar disease severity, age at presentation, and alcohol consumption. (3) Increased serum ferritin and % transferrin saturation were seen in 63% and 29% of ALD patients, regardless of HFE genotype; the increased % transferrin saturation was due to reduced unsaturated iron binding capacity, rather than increased serum iron. (4) Stainable liver iron was present in 52% of patients; grade was greater in patients with two HFE mutations than in those with one or with none. (5) Only the two C282Y homozygote patients had substantial iron overload.
Although serum iron abnormalities are common, C282Y and H63D mutation frequencies were not increased in heavy drinkers with decompensated liver disease. HFE mutations, although modestly influencing liver iron, do not predispose to clinically significant ALD.
酒精性肝病(ALD)的易感性可能部分由遗传因素决定。HFE基因C282Y和/或H63D突变的杂合性与几种肝脏疾病中更严重的病情相关。ALD相关研究尚未使用饮酒量匹配的对照,结果也存在矛盾。
对两个白种人重度饮酒队列(男性>60单位/周,女性>40单位/周,持续>5年)进行HFE基因分型:(a)254例失代偿期ALD患者(Child分级B或C级),(b)130名饮酒量相似但无肝病的对照。还将男性结果与另一项健康男性献血者研究的结果进行了比较。
(1)C282Y和H63D突变的基因型分布在ALD患者、重度饮酒对照和健康献血者中相似。(2)有和没有HFE突变的ALD患者在疾病严重程度、就诊年龄和饮酒量方面相似。(3)无论HFE基因型如何,63%的ALD患者血清铁蛋白升高,29%的患者转铁蛋白饱和度升高;转铁蛋白饱和度升高是由于不饱和铁结合能力降低,而非血清铁升高。(4)52%的患者肝脏有可染色铁;有两个HFE突变的患者铁含量等级高于有一个或没有HFE突变的患者。(5)只有两名C282Y纯合子患者有明显的铁过载。
虽然血清铁异常常见,但在失代偿性肝病的重度饮酒者中,C282Y和H63D突变频率并未增加。HFE突变虽然对肝脏铁有适度影响,但不会导致临床上显著的ALD。